MedPath
NMPA Approval

Lansoprazole for Injection

国药准字H20223831

November 8, 2022

Drug Information

注射用兰索拉唑

注射剂

30mg

化学药品

November 8, 2022

Company Information

Applicant Company

山东省济南市高新区经十东路7000号汉峪金谷A2-4号楼1201、1202室

Manufacturing Company

杭州经济技术开发区一号大街1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用兰索拉唑 - NMPA 批准文号 | MedPath